How to Choose a Hong Kong Fertility Center for Repeated IVF Failures: A Medical Evaluation Guide

AI Abstract

A 41-year-old woman, AMH 0.9, with a history of 4 failed transfers—2 implantation failures, 1 biochemical pregnancy, and 1 miscarriage requiring dilation and curettage. She walked into the consultation room carrying a thick folder of medical records and asked the question most common among patients with repeated failure: “Given my situation, which hospital in Hong Kong is more suitable?”

This is not a question that can be answered with “which hospital is the best.” The causes of repeated failure are highly heterogeneous. The key to choosing a hospital lies not in its reputation, but in the depth of its cause investigation, the level of its laboratory technology, and the doctor's ability to deconstruct complex cases. The following deconstructs the evaluation factors that patients with repeated failure truly need to consider when choosing a Hong Kong hospital, from a reproductive medicine perspective.

Four Core Evaluation Dimensions for Choosing a Hospital for Repeated Failure

Evaluating whether a hospital is suitable for patients with repeated failure should not rely solely on cycle numbers or advertising, but on the actual level of the following four dimensions:

• Embryo Laboratory Quality — Blastocyst culture rate, blastocyst grading standards, vitrification thawing survival rate, biopsy technique and testing platform for PGT-A (Preimplantation Genetic Testing for Aneuploidy). Among patients with repeated failure, approximately 40-60% are related to embryonic chromosomal abnormalities. The laboratory's blastocyst culture ability and genetic screening precision directly determine “whether there is a transferable embryo.”
• Experience with Individualized Protocols — Whether the doctor can adjust the ovarian stimulation protocol, trigger timing, transfer window, and luteal phase support based on the pattern of previous failures. Patients with repeated failure often require “non-standardized” management rather than an assembly-line approach.
• Comprehensive Cause Investigation Capability — Whether routine procedures include hysteroscopy, diagnosis of chronic endometritis (CD138+), ERA (Endometrial Receptivity Array), comprehensive reproductive immunology panel (antiphospholipid antibodies, NK cell activity, T cell subsets, etc.), screening for thrombophilia, and sperm DNA fragmentation testing.
• Level of Multidisciplinary Collaboration — Whether it can integrate reproductive immunology, genetic counseling, hysteroscopy specialists, and psychological support teams to formulate a plan. Repeated failure is often the result of multiple factors叠加, and a single discipline is rarely sufficient to cover all causes.

From a Reproductive Medicine Perspective: Diagnostic Approach to Repeated Failure

As a reproductive specialist, when facing a patient with repeated failure, I would first investigate step by step according to the following logical chain, rather than proceeding directly to the next transfer cycle:

1. Embryo Factor — Review the grading of previously transferred embryos, whether they were blastocysts, and whether PGT-A was performed. If previous transfers were all day-3 cleavage-stage embryos or blastocysts of low grade, prioritize considering embryonic chromosomal abnormalities or poor developmental potential. Recommend PGT-A screening, or consider egg/embryo donation.
2. Uterine Factor — Hysteroscopy to rule out endometrial polyps, adhesions, submucosal fibroids, and endometritis. Among patients with repeated failure, the detection rate of chronic endometritis (CE) is approximately 30-60%, with CD138+ immunohistochemical staining being the gold standard for diagnosis. Additionally, ERA testing can assess whether the window of implantation is displaced.
3. Maternal Factor — Includes endocrine (thyroid function, vitamin D, PRL), metabolic (glucose and lipid metabolism, homocysteine), immune (antiphospholipid syndrome, NK cells, T cell subsets, blocking antibodies), and coagulation (protein S/C, anticardiolipin antibodies, β2 glycoprotein I antibodies) aspects.
4. Male Factor — Sperm DNA fragmentation index (DFI) higher than 30% can affect embryonic developmental potential, even if routine semen parameters are normal. Recommend semen DFI testing and Y chromosome microdeletion screening.

Characteristics of Major Hong Kong Fertility Centers in Managing Repeated Failure

Fertility centers in Hong Kong differ in their technical approaches and clinical styles. The following is an objective comparison based on dimensions most relevant to patients with repeated failure (no ranking, only characteristics listed for reference):

Note: The above information is based on public sources and industry exchanges. The technical capabilities and doctor teams of each center may change with personnel movements. It is recommended to confirm the latest situation during an in-person consultation.

Five Details Easily Overlooked in Repeated Failure

• Missed Diagnosis of Chronic Endometritis (CE) — Routine ultrasound and hysteroscopic morphological examination cannot diagnose CE; CD138+ immunohistochemical staining is mandatory. Many patients with repeated failure have never had this test done at other hospitals, while some Hong Kong centers have already listed it as a routine item for such patients.
• Displaced Window of Implantation — Approximately 20-25% of patients with repeated failure have a displaced window of implantation (advanced or delayed). ERA testing can precisely determine the transfer timing. ERA is available at centers like Hong Kong Sanatorium & Hospital and Gleneagles Hong Kong Hospital, but not all doctors proactively recommend it.
• Ignored Sperm DNA Fragmentation Index (DFI) — Normal routine semen parameters do not guarantee a normal DFI. When DFI > 30%, even if blastocysts form, miscarriage and biochemical pregnancy rates increase significantly. Some Hong Kong centers routinely include DFI in repeated failure evaluations.
• Vitamin D Deficiency — Vitamin D receptors are widely present in the endometrium and immune cells. Serum vitamin D levels < 30 ng/mL are associated with increased risk of repeated failure and miscarriage. This is a low-cost, easily correctable detail.
• Thyroid Autoantibodies — Even with normal TSH, positive thyroid peroxidase antibodies (TPOAb) can affect embryo implantation and early development. Patients with repeated failure should be screened for thyroid autoantibodies, not just TSH.

Interpretation of Key Diagnostic Tests: What Patients with Repeated Failure Should Focus On

The following tests are of high value in evaluating repeated failure, but their availability and interpretive experience vary among hospitals:

Frequently Asked Questions

Practitioner Observations: Common Issues Among Patients with Repeated Failure

In the process of assisting patients with repeated failure in connecting with Hong Kong medical resources, I have noticed several noteworthy phenomena:

• Repeated but not in-depth testing — Many patients bring a large number of reports but lack key items (such as CD138+, ERA, DFI). The core of repeated failure is not the quantity of tests, but their specificity and completeness.
• Misunderstanding of “blastocyst culture rate” — A high blastocyst culture rate does not guarantee success, but a low rate often indicates a laboratory shortfall in blastocyst culture. Patients with repeated failure should prioritize laboratories with a stable blastocyst culture rate above 50%.
• Tendency to overlook male factors — Many patients attribute repeated failure entirely to the female partner. In reality, elevated male DFI or chromosomal polymorphisms account for a significant proportion of repeated failure. Some Hong Kong centers require simultaneous male evaluation for all repeated failure cases.
• Excessive expectations of “immunotherapy” — Reproductive immunology is indeed an important direction for repeated failure, but not all immune abnormalities require treatment, and the effectiveness of immunotherapy protocols (such as IVIG, TNF-α inhibitors) remains controversial. Choosing a center with collaboration from a reproductive immunology specialist is more prudent.

Some Advice for Patients with Repeated Failure

Repeated failure is not a dead end, but it requires a different approach. The following points are for reference:

• Do not blindly proceed to the next transfer cycle; first conduct a systematic investigation. At a minimum, complete: hysteroscopy + CD138+, ERA, initial reproductive immunology screening, and male DFI.
• When choosing a hospital, do not only look at reputation; understand the laboratory's blastocyst culture rate, PGT-A platform, and management process for repeated failure cases. You can request an in-depth consultation with the doctor to assess whether their analysis of your previous failure causes is clear.
• If you have had more than 3 transfers at one center without ever undergoing the above in-depth tests, switching to another hospital for a comprehensive investigation is a reasonable decision. Different doctors' diagnostic approaches and laboratory technologies may differ significantly.
• Manage expectations. Even after a comprehensive investigation, some patients will still fall into the category of “unexplained repeated failure.” In such cases, consider: trying different ovarian stimulation protocols (e.g., natural cycle/mild stimulation), using assisted hatching, trying an artificial endometrium preparation cycle, or considering embryo donation.